CMS Proposes Medicare Advantage, Part D Rule; House Bill Targets 340B
In its Health Care Week in Review, Alston & Bird reports that CMS released a proposed rule implementing Consolidated Appropriations Act, 2026 provisions affecting Medicare Advantage and Part D policies. Separately, a bipartisan group of House members introduced legislation to delay implementation of a rebate-based model for the 340B drug pricing program. The digest also covers additional federal regulatory, legislative, and congressional committee activity from the past week. While these items center on Medicare and 340B rather than Medicaid directly, Medicaid managed care organizations and dual-eligible plan sponsors often track Medicare Advantage rulemaking and 340B developments given overlapping populations and drug pricing interactions.